Sales Ended

Toward Value-Based Decisions in Drug Pricing: What Congress and FDA Can Do to Foster Better and Earlier Communication Between Pharma, Payers, and Other Healthcare Decision-Makers


Follow this organizer to stay informed on future events

By Academy of Managed Care Pharmacy (AMCP)